TCRX shows severe financial deterioration with stockholders' equity collapsing 49% alongside dramatically worsening cash burn, despite a strategic pivot to focus solely on lead candidate TSC-101.
The company appears to be in significant financial distress with equity nearly halved and operating cash flow deteriorating by 22% to -$135M, indicating accelerating cash burn that threatens viability. The strategic shift from a broad TCR platform approach to focusing exclusively on TSC-101 for blood cancers suggests management is narrowing focus amid resource constraints, but this pivot comes as financial metrics are collapsing across the board.
TCRX's financial position has deteriorated dramatically with stockholders' equity plummeting 49% to $123M and total assets shrinking 38% to $229M, while operating cash flow worsened 22% to -$135M despite revenue growing to $10M. The company's cash position declined 15% to $152M while current liabilities decreased 48%, suggesting significant balance sheet restructuring amid financial stress. The combination of massive equity destruction, worsening cash burn, and overall asset base contraction signals a company in severe financial distress that may struggle to fund operations without immediate capital infusion.
Strong top-line growth of 266.7% — accelerating demand or successful expansion into new markets.
Equity declined sharply — large losses, buybacks, or write-downs reducing book value significantly.
Current liabilities reduced — improved short-term financial position and working capital health.
Current assets declined 46.3% — monitor working capital adequacy and short-term liquidity.
Total assets contracted 38.4% — asset sales, write-downs, or balance sheet optimization underway.
Interest expense declined — debt repayment or refinancing at lower rates improving earnings quality.
Operating cash flow softened — monitor whether temporary working capital timing or structural deterioration.
Liabilities reduced 18.8% — deleveraging improves balance sheet strength and financial flexibility.
Cash decreased 14.7% — monitor burn rate and upcoming capital needs.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →